Antitumor effects of the fusion protein of transmembrane-staphylococcal enterotoxin A

马文学,余海,王青青,金洪传,鲍建芳,易平勇,黄常新,李经忠
2003-01-01
Abstract:AIM: To prepare transmembrane-staphylococcal enterotoxin A fusion protein(TM-SEA) vaccine and to study its antitumor effect and the related mechanism. METHODS: The B16 melanoma model of C57BL/6 mice was established, the antitumor effect and the protective immunity elicited by the B16-TM-SEA tumor vaccine were investigated, the natural killer(NK) and cytotoxicity T lymphocytes (CTL) activity of the splenocytes derived from the treated and immunized mice were measured by LDH release assay. RESULTS: Tumor growth was inhibited and the survival time prolonged significantly in melanoma-bearing mice treated with the B16-TM-SEA tumor vaccine. The NK and CTL activity of splenocytes derived from the mice treated with the B16-TM-SEA vaccine increased significantly as compared with those in controls. Immunization of the mice with the B16-TM-SEA vaccine elicited protective immunity against the following tumor challenge of B16 cells. Higher CTL activity was induced in vaccinated mice than that in unvaccinated mice. CONCLUSION: The tumor vaccine based on TM-SEA fusion protein could elicit strong antitumor effect through more efficient induction of specific and nonspecific antitumor immune responses. This tumor vaccine may be as an efficient approach used for the treatment of cancer recurrence and micro-metastasis.
What problem does this paper attempt to address?